Better, faster and more accessible healthcare, enabling world-class leadership teams to succeed on the global stage.
  • Specialist
  • Healthcare
    • Sub-sector Focus
    • Portfolio
    • Case Studies
  • Partners
    • About
    • Our Team
    • Responsible Investing
    • Careers
  • Investor portal
  • Navigate
  • Specialist
  • Healthcare
    • Sub-sector Focus
    • Portfolio
    • Case Studies
  • Partners
    • About
    • Our Team
    • Responsible Investing
    • Careers
  • News + Updates

Investor Relations

IR Portal Investor Privacy Notice

Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London.

Contact us

News + Updates

GHO Capital Updates

GHO Capital Appoints Jim Datin, former President and CEO of BioAgilityx, as Operating Partner

+Read Update
Envision Pharma Group

Envision Pharma Group acquires OKRA.ai

+Read Update
Sterling Pharma Solutions

Sterling Pharma Solutions Completes Acquisition of API Manufacturing Facility in Ringaskiddy, Ireland

+Read Update
Velocity Clinical Research

Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business

+Read Update
Sapio Sciences

GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company

+Read Update
Biocare Medical

Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research

+Read Update
Velocity Clinical Research

Velocity Clinical Research expands to UK

+Read Update
Alcami

GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand Capital Partners

+Read Update
  • Privacy Policy
  • Contact us
  • Website Terms and Conditions

Our portfolio

High-growth healthcare businesses in specialist subsectors

Filter companies
Showing:
  • All companies
Clear all
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Stripe logo Stripe logo
Load more

Portfolio News

Envision Pharma Group

Envision Pharma Group acquires OKRA.ai

+Read Update
Sterling Pharma Solutions

Sterling Pharma Solutions Completes Acquisition of API Manufacturing Facility in Ringaskiddy, Ireland

+Read Update
Velocity Clinical Research

Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business

+Read Update
Sapio Sciences

GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company

+Read Update
Biocare Medical

Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research

+Read Update
Velocity Clinical Research

Velocity Clinical Research expands to UK

+Read Update
Alcami

GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand Capital Partners

+Read Update
Velocity Clinical Research

Velocity Clinical Research growth skyrockets with eight site acquisitions

+Read Update
RoslinCT

RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO

+Read Update
Velocity Clinical Research

Velocity Clinical Research begins European expansion with German site acquisition

+Read Update
Genesis Research

Genesis Research to Acquire Market Access Transformation, a Leading Provider of Technology-Enabled Payer Research Platforms

+Read Update
Validant

GHO Capital announces increased investment in Validant, alongside management, to accelerate global build-out

+Read Update
Sign-up to receive the latest updates to your inbox

By clicking submit you consent to receiving email news, alerts, updates and marketing information from or on behalf of GHO. We will process your personal data in accordance with applicable data protection laws. You can unsubscribe at any time by clicking the link at the bottom of each email.

GHO Capital
  • +44 20 3700 7440
  • [email protected]
  • 21 St James’s Square
    London SW1Y 4JZ
    Directions
  • Privacy Policy
  • Contact us
  • Website Terms and Conditions
© 2023 — GHO Capital. All rights reserved.
Website by Alchemy Digital